Obsessive-compulsive disorder: a concealed diagnosis

Area of Science:

• Neuroscience
• Psychiatry
• Epidemiology

Background:

• Obsessive-compulsive disorder (OCD) is a prevalent mental disorder, comparable in frequency to chronic conditions like asthma and diabetes.
• Epidemiological data rank OCD as the fourth most common mental disorder, following phobias, substance abuse, and depression.

Purpose of the Study:

• To review the current understanding and treatment of obsessive-compulsive disorder.
• To highlight the role of neuroimaging and pharmacotherapy in managing OCD.
• To emphasize the importance of family physicians in early recognition and treatment planning for OCD.

Main Methods:

• Review of epidemiological data on obsessive-compulsive disorder prevalence.
• Analysis of findings from positron emission tomographic (PET) scanning in OCD patients.
• Evaluation of the efficacy of selective serotonin reuptake inhibitors (SSRIs) in symptom alleviation.
• Summary of current treatment modalities including pharmacotherapy, behavior therapy, and family therapy.

Main Results:

• Positron emission tomographic scanning reveals distinct alterations in cerebral metabolism in individuals with OCD.
• Selective serotonin reuptake inhibitors (SSRIs) have demonstrated significant efficacy in reducing OCD symptoms.
• Comprehensive treatment approaches, encompassing medication, behavioral interventions, and family support, are effective.

Conclusions:

• Significant advancements in understanding and treating obsessive-compulsive disorder have been achieved.
• Integrated treatment strategies involving pharmacotherapy, psychotherapy, and family involvement are crucial for managing OCD.
• Family physicians are vital in identifying OCD and facilitating appropriate, effective treatment plans to reduce patient suffering.